Plakoglobin-dependent disruption of the desmosomal plaque in pemphigus vulgaris. 2007

Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
Institute of Animal Pathology and DermFocus Vetsuisse Faculty, Berne, Switzerland.

We recently reported that the pathogenesis of pemphigus vulgaris (PV), an autoimmune blistering skin disorder, is driven by the accumulation of c-Myc secondary to abrogation of plakoglobin (PG)-mediated transcriptional c-Myc suppression. PG knock-out mouse keratinocytes express high levels of c-Myc and resemble PVIgG-treated wild-type keratinocytes in most respects. However, they fail to accumulate nuclear c-Myc and loose intercellular adhesion in response to PVIgG-treatment like wild-type keratinocytes. This suggested that PG is also required for propagation of the PVIgG-induced events between augmented c-Myc expression and acantholysis. Here, we addressed this possibility by comparing PVIgG-induced changes in the desmosomal organization between wild-type and PG knock-out keratinocytes. We found that either bivalent PVIgG or monovalent PV-Fab (known to trigger blister formation in vivo) disrupt the linear organization of all major desmosomal components along cell borders in wild-type keratinocytes, simultaneously with a reduction in intercellular adhesive strength. In contrast, PV-Fab failed to affect PG knock-out keratinocytes while PVIgG cross-linked their desmosomal cadherins without significantly affecting desmoplakin. These results identify PG as a principle effector of the PVIgG-induced signals downstream of c-Myc that disrupt the desmosomal plaque at the plasma membrane.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D003896 Desmosomes A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Desmosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
April 1997, The Journal of investigative dermatology,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
January 1994, Dermatology (Basel, Switzerland),
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
May 2007, Journal of the American Academy of Dermatology,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
October 2002, Journal of cutaneous pathology,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
February 2013, Cell communication & adhesion,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
September 1989, The New England journal of medicine,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
May 1996, The Journal of biological chemistry,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
December 1994, Differentiation; research in biological diversity,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
December 1994, The Journal of biological chemistry,
Alain de Bruin, and Reto Caldelari, and Lina Williamson, and Maja M Suter, and Thomas Hunziker, and Marianne Wyder, and Eliane J Müller
July 2009, The Journal of investigative dermatology,
Copied contents to your clipboard!